{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T18:00:18Z","timestamp":1762020018495,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016924","name":"National Cerebral and Cardiovascular Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jns.2020.116704","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:20:23Z","timestamp":1579692023000},"page":"116704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Concentrations of dabigatran administered after acute ischemic stroke"],"prefix":"10.1016","volume":"411","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2129-9462","authenticated-orcid":false,"given":"Shinichi","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-3538","authenticated-orcid":false,"given":"Sohei","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-4048","authenticated-orcid":false,"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-4026","authenticated-orcid":false,"given":"Masatoshi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116704_bb0005","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.116704_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/STROKEAHA.111.622498","article-title":"Using dabigatran in patients with stroke a practical guide for clinicians","volume":"43","author":"Alberts","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.116704_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1747493016632239","article-title":"Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-nonvalvular atrial fibrillation (NVAF) study","volume":"11","author":"Arihiro","year":"2016","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jns.2020.116704_bb0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","article-title":"Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis","volume":"6","author":"Giles","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.116704_bb0025","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/STROKEAHA.107.505438","article-title":"Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke","volume":"39","author":"Ois","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.116704_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2146\/ajhp160168","article-title":"Successful use of laboratory monitoring to facilitate an invasive procedure for a patient treated with dabigatran","volume":"74","author":"Byron","year":"2017","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jns.2020.116704_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY trial (randomized evaluation of long-term anticoagulation therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2020.116704_bb0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ahj.2009.02.005","article-title":"Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran","volume":"157","author":"Ezekowitz","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jns.2020.116704_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11239-014-1125-y","article-title":"Monitoring of dabigatran therapy using Hemoclot(\u00ae) thrombin inhibitor assay in patients with atrial fibrillation","volume":"39","author":"Samos","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jns.2020.116704_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.joa.2014.11.003","article-title":"Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation","volume":"31","author":"Shimomura","year":"2015","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.jns.2020.116704_bb0055","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2020.116704_bb0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2013.11.013","article-title":"Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)","volume":"63","author":"Goodman","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2020.116704_bb0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1253\/circj.CJ-11-0191","article-title":"Efficacy and safety of dabigatran vs, warfarin in patients with atrial fibrillation\u2014sub-analysis in Japanese population in RE-LY trial","volume":"75","author":"Hori","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.jns.2020.116704_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bcpt.12417","article-title":"Dabigatran concentration: variability and potential bleeding prediction in \u201creal\u2013life\u201d patients with atrial fibrillation","volume":"117","author":"\u0160inigoj","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jns.2020.116704_bb0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1160\/TH11-09-0656","article-title":"A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgery","volume":"107","author":"Dansirikul","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jns.2020.116704_bb0080","article-title":"The impact of proton pump inhibition on dabigatran levels in patients with atrial fibrillation","author":"Bolek","year":"2017","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.jns.2020.116704_bb0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.joa.2017.07.013","article-title":"Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non-valvular atrial fibrillation","volume":"33","author":"Kuwayama","year":"2017","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.jns.2020.116704_bb0090","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1253\/circj.CJ-18-0067","article-title":"Two-year outcomes of anticoagulation for acute ischemic stroke with nonvalvular atrial fibrillation -SAMURAI-NVAF study","volume":"82","author":"Yoshimura","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.jns.2020.116704_bb0095","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","article-title":"Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jns.2020.116704_bb0100","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/jama.2015.4369","article-title":"Stroke prevention in atrial fibrillation: a systematic review","volume":"313","author":"Lip","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2020.116704_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.joa.2015.11.008","article-title":"Post-marketing surveillance on the long term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: preliminary report of the J-dabigatran surveillance","volume":"32","author":"Inoue","year":"2016","journal-title":"J. Arrhythm."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2030040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2030040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:48:38Z","timestamp":1758383318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2030040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":21,"alternative-id":["S0022510X2030040X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116704","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concentrations of dabigatran administered after acute ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116704"}}